Загрузка...
Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
Skeletal muscle depletion is common in patients with advanced cancer and may be associated with a poor outcome. To investigate whether the changes in skeletal muscle in metastatic renal cell carcinoma (mRCC) patients receiving targeted therapy are associated with clinical outcome, we undertook an ob...
Сохранить в:
| Опубликовано в: : | Sci Rep |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5548774/ https://ncbi.nlm.nih.gov/pubmed/28790354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-07955-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|